Eflapegrastim, sold under the brand name Rolvedon among others, is a long-acting G-CSF analog developed by Hanmi Pharmaceutical and licensed to Spectrum...
8 KB (495 words) - 01:46, 9 May 2024
assets. As of 2023, Spectrum has one FDA approved drug (ROLVEDON™ (eflapegrastim) is also formerly known as Rolontis) and one drug in advanced development...
9 KB (1,094 words) - 17:27, 6 July 2024
Empegfilgrastim L03AA17 Pegteograstim L03AA18 Efbemalenograstim alfa L03AA19 Eflapegrastim QL03AA90 Pegbovigrastim L03AB01 Interferon alfa natural L03AB02 Interferon...
2 KB (353 words) - 05:13, 18 December 2023